发明名称 |
Neurodegenerative diseases and methods of modeling |
摘要 |
This invention relates to methods for neuroprotection, promoting survival of motor neurons and the treatment of motor neuron diseases by preventing cell signaling through the classic prostaglandin D2 receptor DP1. |
申请公布号 |
US9180114(B2) |
申请公布日期 |
2015.11.10 |
申请号 |
US200912570476 |
申请日期 |
2009.09.30 |
申请人 |
PRESIDENT AND FELLOWS OF HARVARD COLLEGE |
发明人 |
Eggan Kevin;DiGiorgio Francesco Paolo |
分类号 |
A61K31/403;A61K31/40;A61K31/4164;A61K31/7052 |
主分类号 |
A61K31/403 |
代理机构 |
Morse, Barnes-Brown & Pendleton, P.C. |
代理人 |
Warren, Esq. Lisa M.;Morse, Barnes-Brown & Pendleton, P.C. |
主权项 |
1. A method of treating motor neuron disease, the method comprising administering an inhibitor of a prostaglandin D2 DP1 receptor comprising the compound of formula (II) to a subject in need thereof, wherein the inhibitor inhibits expression or activity the prostaglandin D2 DP1 receptor, wherein the motor neuron disease is amyotrophic lateral sclerosis (ALS), and wherein: R1 is H or C1-C6 alkyl; R2 is aryl or heteroaryl, each of which can be optionally substituted; R3 and R4 are each independently is halo, —CF3, —CN, —NO2, —S(═O)alkyl, —SO2alkyl, C1-C6 alkyl; —C(O)alkyl, —CH(OH)alkyl; and m is 1, 2 or 3. |
地址 |
Cambridge MA US |